Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (116)	2/14/2000 6:36:00 PM
From: scaram(o)uche	Respond to of 362

Monday February 14, 6:13 pm Eastern Time Company Press Release SOURCE: The American Stock Exchange The American Stock Exchange Plans Trading in Options On Titan Pharmaceuticals Inc. NEW YORK, Feb. 14 /PRNewswire/ -- The American Stock Exchange plans to start trading options of The American Stock Exchange-listed stock of Titan Pharmaceuticals Inc. (TTP) on Friday, February 18, 2000. Titan Pharmaceuticals, Inc. develops novel and proprietary products for the improved treatment of cancer and central nervous system disorders. The Company has six products in human testing, including a lead product being developed for the treatment of schizophrenia and related psychotic disorders. Titan is also developing therapeutics for cancer and Parkinson's disease. Symbols: TTP Position/ Exercise 31,500 (Option/Stock) Limits Cycle: January Strike Prices: 30 - 35 - 40 Expiration Months: March Specialist Unit: Charlton, SLK April July October Post: 17 The American Stock Exchange trades options on 26 broad-based and sector indexes and 1,185 domestic and foreign stocks, as well as Long-term Equity AnticiPation Securities© (LEAPS©) on 234 stocks. Amex is a leader in listing warrants on indexes, hybrid instruments and other structured products. The Amex is home to the Index Share(TM) Marketplace, which includes SPDRs©, Select Sector SPDRs©, DIAMONDS©, MidCap SPDRs(TM), WEBS(TM) and Nasdaq-100 Shares(SM). SOURCE: The American Stock Exchange

To: Miljenko Zuanic who wrote (116)	2/14/2000 6:36:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 362

Monday February 14, 6:13 pm Eastern Time Company Press Release SOURCE: The American Stock Exchange The American Stock Exchange Plans Trading in Options On Titan Pharmaceuticals Inc. NEW YORK, Feb. 14 /PRNewswire/ -- The American Stock Exchange plans to start trading options of The American Stock Exchange-listed stock of Titan Pharmaceuticals Inc. (TTP) on Friday, February 18, 2000. Titan Pharmaceuticals, Inc. develops novel and proprietary products for the improved treatment of cancer and central nervous system disorders. The Company has six products in human testing, including a lead product being developed for the treatment of schizophrenia and related psychotic disorders. Titan is also developing therapeutics for cancer and Parkinson's disease. Symbols: TTP Position/ Exercise 31,500 (Option/Stock) Limits Cycle: January Strike Prices: 30 - 35 - 40 Expiration Months: March Specialist Unit: Charlton, SLK April July October Post: 17 The American Stock Exchange trades options on 26 broad-based and sector indexes and 1,185 domestic and foreign stocks, as well as Long-term Equity AnticiPation Securities© (LEAPS©) on 234 stocks. Amex is a leader in listing warrants on indexes, hybrid instruments and other structured products. The Amex is home to the Index Share(TM) Marketplace, which includes SPDRs©, Select Sector SPDRs©, DIAMONDS©, MidCap SPDRs(TM), WEBS(TM) and Nasdaq-100 Shares(SM). SOURCE: The American Stock Exchange